660431-66-3

Basic information

• Product Name: α-Tosyl-(2,4-difluorobenzyl)isocyanide
• Synonyms: α-Tosyl-(2,4-difluorobenzyl)isocyanide;a-Tosyl-(2,4-difluorobenzyl)isocyanide;2,4-Difluoro-1-(isocyano(tosyl)methyl)benzene;2,4-Difluoro-1-[isocyano-(toluene-4-sulfonyl)-methyl]-benzene;2,4-difluoro-1-[isocyano[(4-methylphenyl)sulfonyl]methyl]benzene
• CAS NO: 660431-66-3
• Molecular Formula: C₁₅H₁₁F₂NO₂S
• Molecular Weight: 307.319
• Mol File: 660431-66-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: α-Tosyl-(2,4-difluorobenzyl)isocyanide(CAS DataBase Reference)
• NIST Chemistry Reference: α-Tosyl-(2,4-difluorobenzyl)isocyanide(660431-66-3)
• EPA Substance Registry System: α-Tosyl-(2,4-difluorobenzyl)isocyanide(660431-66-3)

Safety Data

• Hazardous Substances Data: 660431-66-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
α-Tosyl-(2,4-difluorobenzyl)isocyanide is used as a versatile building block for the synthesis of various organic compounds, contributing to the development of new chemical entities.
Used in Pharmaceutical Industry:
α-Tosyl-(2,4-difluorobenzyl)isocyanide is used as a reagent in the synthesis of pharmaceuticals, aiding in the production of drugs with potential therapeutic applications.
Used in Agrochemical Industry:
α-Tosyl-(2,4-difluorobenzyl)isocyanide is used as a component in the preparation of agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Used in the Synthesis of Heterocycles:
α-Tosyl-(2,4-difluorobenzyl)isocyanide is used as an effective reagent for the synthesis of various heterocycles, which are important in the development of complex molecular structures with potential applications in different fields.
Safety Consideration:
It is important to handle α-Tosyl-(2,4-difluorobenzyl)isocyanide with care, as isocyanides are known to be toxic and can pose a risk to human health. Proper safety measures should be implemented during its use in laboratories and industrial settings.

Upstream product

• 668990-82-7 N-[(2.4-difluoro-phenyl)-(toluene-4-sulfonyl)-methyl]-formamide 
• 536-57-2 p-toluene sulfinic acid 
• 1550-35-2 2,4-difluorobenzaldehyde 

Downstream Products

• 1902955-29-6 methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate 

Relevant articles and documents

A 4 - methoxy pyrrole intermediate preparation method

The present invention provides 4 - methoxy pyrrole intermediate preparation method, comprises the following steps: (1) of formula (I) compound 2, 4 - difluorobenzaldehyde with formula (II) compound to the [...] sulfonic acid in the alkaline solvent and th

DI AND TRIFLUORO-TRIAZOLO-PYRIDINES ANTI-INFLAMMATORY COMPOUNDS

The present invention relates to novel triazolo-pyridines of the formula (I) wherein R1 is fluoro; s is an integer from two to three; R2 is (C3-C6)cycloalkyl optionally substituted by one or two moieties independently selected from the group consisting of halo, (Cl-C4)alkyl, hydroxy, (Cl-C6)alkoxy and (C1-C6)alkyl-(C=O)-0-; or R2 is (Cl-C6)alkyl optionally substituted by one or two moieties independently selected from the group consisting of halo, (C1-C6)alkyl, hydroxy, (C1-C6)alkoxy and (C1-C6)alkyl-(C=O)-0-; with the proviso that said compound of formula (I) cannot be 6-[4-(2,4-Difluoro-phenyl)-oxazol-5-yl]-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine; or 6-[4-(3,4-Difluoro-phenyl)-oxazol-5-yl]-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine; to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases, preferably p38 kinase. They are useful in the treatment of inflammation, osteoarthritis, rheumatoid arthritis, cancer, repurfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.

Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines

The present invention relates to novel cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]triazolo-pyridines, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases, preferably p38 kinase. They are useful in the treatment of inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.